Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-31 5:17 pm Sale |
2023-08-31 | 13D | Pardes Biosciences, Inc. PRDS |
FS Development Holdings II LLC | 1,000 100.000% |
-16,812,146 (-99.99%) |
Filing History |
| 2023-08-14 4:31 pm Purchase |
2023-08-02 | 13G | Pardes Biosciences, Inc. PRDS |
Beryl Capital Management LLC | 4,859,426 7.800% |
4,859,426 (New Position) |
Filing History |
| 2023-07-17 07:55 am Unchanged |
2023-07-16 | 13D | Pardes Biosciences, Inc. PRDS |
FS Development Holdings II LLC | 16,813,146 27.240% |
0 (Unchanged) |
Filing History |
| 2023-04-21 4:28 pm Unchanged |
2023-04-20 | 13D | Pardes Biosciences, Inc. PRDS |
FS Development Holdings II LLC | 16,813,146 27.240% |
0 (Unchanged) |
Filing History |
| 2023-04-06 9:07 pm Purchase |
2023-04-05 | 13D | Pardes Biosciences, Inc. PRDS |
FS Development Holdings II LLC | 16,813,146 27.240% |
1,547,904 (+10.14%) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Pardes Biosciences, Inc. PRDS |
RA Capital Management, L.P. | 0 0.000% |
-4,431,901 (Position Closed) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Pardes Biosciences, Inc. PRDS |
PRICE T ROWE ASSOCIATES INC | 6,166 0.000% |
-3,206,309 (-99.81%) |
Filing History |
| 2023-02-08 5:09 pm Unchanged |
2023-02-08 | 13G | Pardes Biosciences, Inc. PRDS |
BML Investment Partners, L.P. | 4,867,984 7.800% |
0 (Unchanged) |
Filing History |
| 2023-01-23 4:23 pm Purchase |
2023-01-13 | 13G | Pardes Biosciences, Inc. PRDS |
Lynx1 Capital Management LP | 3,139,202 5.000% |
3,139,202 (New Position) |
Filing History |
| 2022-12-30 5:30 pm Purchase |
2022-12-21 | 13G | Pardes Biosciences, Inc. PRDS |
BML Investment Partners, L.P. | 4,867,984 7.800% |
4,867,984 (New Position) |
Filing History |
| 2022-12-05 4:23 pm Purchase |
2022-12-01 | 13D | Pardes Biosciences, Inc. PRDS |
FS Development Holdings II LLC | 15,265,242 24.490% |
637,420 (+4.36%) |
Filing History |
| 2022-02-14 4:49 pm Purchase |
2021-12-31 | 13G | Pardes Biosciences, Inc. PRDS |
VK Services LLC | 6,151,766 9.900% |
6,151,766 (New Position) |
Filing History |
| 2022-02-07 4:01 pm Purchase |
2021-12-23 | 13D | Pardes Biosciences, Inc. PRDS |
Lopatin Uri A | 5,697,287 9.100% |
5,697,287 (New Position) |
Filing History |
| 2022-01-28 1:41 pm Purchase |
2021-12-31 | 13G | Pardes Biosciences, Inc. PRDS |
Frazier Life Sciences Public Fund, L.P. | 2,457,507 3.900% |
2,457,507 (New Position) |
Filing History |
| 2022-01-10 5:00 pm Purchase |
2021-12-29 | 13G | Pardes Biosciences, Inc. PRDS |
RA Capital Management, L.P. | 4,431,901 7.100% |
4,431,901 (New Position) |
Filing History |
| 2022-01-10 2:12 pm Purchase |
2021-12-31 | 13G | Pardes Biosciences, Inc. PRDS |
PRICE T ROWE ASSOCIATES INC | 3,212,475 5.100% |
3,212,475 (New Position) |
Filing History |
| 2021-12-30 5:09 pm Purchase |
2021-12-23 | 13D | Pardes Biosciences, Inc. PRDS |
FS Development Holdings II LLC | 14,627,822 23.450% |
14,627,822 (New Position) |
Filing History |
| 2021-12-17 2:36 pm Purchase |
2021-12-07 | 13G | FS Development Corp. II FSII |
Frazier Life Sciences Public Fund, L.P. | 1,113,700 5.400% |
1,113,700 (New Position) |
Filing History |
| 2021-12-13 11:36 am Purchase |
2021-11-30 | 13G | FS Development Corp. II FSII |
PRICE T ROWE ASSOCIATES INC | 2,542,852 12.200% |
2,542,852 (New Position) |
Filing History |